Skip to main content
. 2022 Feb 15;9:833171. doi: 10.3389/fcvm.2022.833171

Figure 1.

Figure 1

Age-adjusted marginal mean (95% Confidence Interval) estimates of echocardiography and cardiopulmonary exercise testing measures according to exposure group. The figure presents the age-adjusted marginal mean (95% confidence interval) estimates based on analysis of covariance for measures of systolic function, diastolic function and cardiopulmonary exercise testing according to exposure group including (a) BRCA1/2 mutation carriers exposed to doxorubicin, (b) BRCA1/2 mutation carriers not exposed to doxorubicin, and (c) BRCA1/2 mutation non-carriers exposed to doxorubicin. For longitudinal and circumferential strain, absolute values are presented, where by a higher value represents greater function.